Drug intelligence / Profile preview

somatropin + testosterone enanthate

Development stage
Phase 1
Lead developer
University of Rochester
Modality
Small Molecules, Recombinant Proteins and Enzymes
Administration
Subcutaneous, Intramuscular
01

Overview

This combination therapy, investigated by the University of Rochester, consists of recombinant human growth hormone (somatropin, administered as Genotropin) and testosterone enanthate. It is designed to treat facioscapulohumeral muscular dystrophy (FSHD) by leveraging the synergistic effects of growth hormone and androgen receptor signaling. Somatropin acts as an agonist at the growth hormone receptor to stimulate protein synthesis and muscle growth, while testosterone enanthate targets the androgen receptor to further enhance lean body mass and muscle strength. The therapy was evaluated in the Phase 1 STARFiSH (Study of Testosterone and rHGH in FSHD) trial, which focused on safety, tolerability, and proof-of-concept efficacy in adult men with genetically confirmed FSHD.

Other names
rHGH + testosteronerecombinant human growth hormone + testosterone enanthatesomatropin + testosterone
02

Targets

AR (Adrenergic receptors)GHR (Growth hormone receptor)

Beyond the preview

Go deeper on somatropin + testosterone enanthate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on somatropin + testosterone enanthate.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call